Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

<jats:title>Key Points</jats:title> <jats:p>Acquired pathogenic mutations in SAMHD1 are found in up to 11% of relapsed/refractory patients with CLL. SAMHD1 is mobilized to sites of DNA damage.</jats:p>

Original publication

DOI

10.1182/blood-2013-04-490847

Type

Journal article

Journal

Blood

Publisher

American Society of Hematology

Publication Date

13/02/2014

Volume

123

Pages

1021 - 1031